Mark Selby

3PUBLICATIONS
40CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Mar 16, 2026
Improving Anti-CTLA-4 Therapies through Peptide Masking and Fragment Crystallizable Non-fucosylation: Preclinical Characterization of Three Novel Antibodies.

Amy Jhatakia, Xin Sun, Alessandra Vaccaro

|Aug 18, 2022
Preclinical Characterization of Relatlimab, a Human LAG-3-Blocking Antibody, Alone or in Combination with Nivolumab.

Kent Thudium, Mark Selby, Julie A Zorn

|Mar 24, 2021
Fc-Optimized Anti-CCR8 Antibody Depletes Regulatory T Cells in Human Tumor Models.

Joseph R Campbell, Bryan R McDonald, Paul B Mesko

Pageof 1